A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
Trials
; 21(1): 436, 2020 May 27.
Article
in En
| MEDLINE
| ID: mdl-32460885
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Speech Therapy
/
Voice
/
Voice Disorders
/
Language Therapy
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2020
Type:
Article
Affiliation country:
United kingdom